Trade AstraZeneca AZN

AstraZeneca live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

AstraZeneca News

Emma Rose 2025 Nov 15, 00:00

US Stock Market Outlook: Jitters and Potential Catalysts

Ava Grace 2025 Nov 15, 00:00

Fiscal Firefighting: US & Japan's Unorthodox Inflation Strategy

Sophia Claire 2025 Nov 15, 00:00

Guggenheim Partners Sees Fed Rate Cut in December Amid Economic Slowdown Concerns

Ava Grace 2025 Nov 15, 00:00

US Government Shutdown Aftermath: Rate Cut Concerns and Market Uncertainty

Sophia Claire 2025 Nov 15, 00:00

El-Erian Flags Economic Worries: Low-Income Consumers & Debt Refinancing

Frances Wang 2025 Nov 13, 16:00

Commodity market today: Gold prices are rising, what is XAU/USD prediction?

Frances Wang 2025 Nov 13, 16:00

AI stocks are trending: Qualcomm stock, Nvidia (NVDA), AMD stock

Ghko B 2025 Nov 12, 16:00

VOO performance analysis: What is the VOO ETF performance prediction?

Ghko B 2025 Nov 12, 16:00

Easy stocks for beginners: MSFT stock, AAPL stock, NVIDIA (NASDAQ: NVDA)

Frances Wang 2025 Nov 12, 16:00

Stellar climbs 4% today: Stellar (XLM) Price Prediction for 2025, 2026, 2030

Latest news

Show more
Sophia Claire 2025 Nov 15, 18:10

Blockchain and Crypto Treasury Strategies Revolutionizing Biomedical Research Funding

Emma Rose 2025 Nov 15, 12:40

Aster Clarifies Tokenomics Amid Unlock Schedule Confusion

Liam James 2025 Nov 15, 10:40

Robert Kiyosaki: I'm Not Selling My Bitcoin or Gold Amid Market Turmoil, I'll Buy More

Sophia Claire 2025 Nov 15, 10:10

Wall Street Cautious: Fed Rate Cut Doubts, Data Deluge, and Nvidia Earnings Loom

Sophia Claire 2025 Nov 15, 10:10

Wall Street Cautious Amid Economic Data Deluge, Fed Rate Cut Uncertainty, and Bitcoin's Slide

Emma Rose 2025 Nov 15, 09:30

Crypto Market Updates: SEC, ETFs, Saylor, Binance, ARK

Liam James 2025 Nov 15, 07:40

Curve Finance: Evolution into a DeFi Liquidity Cornerstone and Sustainability

Noah Lee 2025 Nov 15, 07:20

ARK Invest Boosts Crypto Equity Holdings: BitMine & Bullish Acquisitions

Info

Spread

83.20

Spread (%)

0.6167 %

Leverage

1:10

Overnight Interest Buy

-0.0590 %

Overnight Interest Sell

-0.0299 %

Currency

PNC

Trading Hours

Markets closed

Monday

08:01 - 11:59

Tuesday

08:01-11:59

Tuesday

12:03-16:29

Wednesday

08:01-11:59

Wednesday

12:03-16:29

Thursday

08:01-11:59

Thursday

12:03-16:29

Friday

08:01-11:59

Friday

12:03-16:29

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

210155732992

Shares Outstanding

1550270564

Earnings Date (Next)

0000-00-00

Div Yield

Ex-Dividend Date

2025-08-07

Forward annual dividend rate

2.45

Forward annual dividend yield

0.0181

EPS

4.59

Learn more about this instrument

AstraZeneca AstraZeneca PLC
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Crestor, Seloken, Lokelma, Roxadustat, Andexxa, Wainua, Symbicort, Fasenra, Pulmicort, Breztri/Trixeo, Saphnelo, Tezspire, Airsupra, Ultomiris, Soliris, Strensiq, Koselugo, Kanuma, Atacand, Plendil, Modip, Splendil, Munobal, Flodil, Komboglyze, Qtern, Byetta, XIGDUO, Accolate, Accoleit, Vanticon, Beyfortus, Synagis, FluMist, tixagevimab and cilgavimab, and sipavibart. It also provides Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Bricanyl Turbuhaler, Rhinocort, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Breztri Aerosphere, Duaklir Genuair, Kavigale, Evusheld, Fluenz/FluMist, and Voydeya. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the United States, Europe, and Asia. It has a strategic agreement with Tempus to develop the largest multimodal foundation model in oncology. The company has a collaboration agreement with IonQ, Inc. for the development of quantum-accelerated computational chemistry workflow for healthcare, life sciences, and chemistry; a strategic research collaboration with CSPC Pharmaceutical Group Limited to advance the discovery and development of novel oral candidates, with the potential to treat diseases across multiple indications; and collaboration Revna Biosciences for lung cancer treatment. AstraZeneca PLC was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Nov 13, 16:00

Which broker is best for bitcoin trading: Cheapest Ways to Buy Bitcoin In 2026

Ghko B 2025 Nov 13, 16:00

Crypto day trading strategy: How to day trade crypto as a beginner?

Ghko B 2025 Nov 13, 16:00

Commodity trading strategy: WTI Oil faces potential decline, what’s next?

Trustpilot